Status:
COMPLETED
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Lead Sponsor:
Alcon Research
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Compare the effect of Xalatan with benzalkonium chloride on the ocular surface to those effects observed with Travatan Z without benzalkonium chloride after a single dose
Eligibility Criteria
Inclusion
- Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma
Exclusion
- Age
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00468988
Start Date
May 1 2007
End Date
July 1 2007
Last Update
May 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando
Orlando, Florida, United States, 32801